ECG
Interim CEO Ira Bahr said that his company is undeterred by Apple's entrance into the mobile ECG market.
The collaboration will investigate heart health outcomes and medication adherence among seniors, and is scheduled to begin in 2019.
At WISH in Doha Qatar last month, Glazkova was a featured young entrepreneur for her Sense2beat technology.
The investigation compared tests from 204 STEMI patients presenting in five different settings.
This is the first FDA clearance for Apple and pushes the Watch further into healthcare than ever before.